ANNEX 3 Linies.pdf - Fundació Institut d'Investigació en Ciències de ...

IF: 5,673
Barba, I; Sanz, C; Barbera, A; Tapia, G; Mate, JL; Garcia-Dorado, D; Ribera, JM; Oriol, A
Metabolic fingerprinting of fresh lymphoma samples used to discriminate between follicular and diffuse large B-cell lymphomas
EXP HEMATOL 2009 NOV;37:1259-1265
IF: 3,106
Bartolucci, R; Wei, J; Sanchez, JJ; Perez-Roca, L; Chaib, I; Puma, F; Farabi, R; Mendez, P; Roila, F; Okamoto, T; Taron, M; Rosell, R
XPG mRNA Expression Levels Modulate Prognosis in Resected Non-Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1
Expression
CLIN LUNG CANCER 2009-JAN; 10 (1): 47-52
IF: 1,509
Boix, R; Sanz, C; Mora, M; Quer, A; Beyer, K; Musulen, E; Gonzalez, C; Bayona, S; Saladie, JM; Ariza, A
Primary Renal Cell Carcinoma in a Transplanted Kidney: Genetic Evidence of Recipient Origin
TRANSPLANTATION 2009-APR 15; 87 (7): 1057-1061
IF: 3,498
Brüggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, Benoit Y, Biondi A, Cavé
H, Dombret H, Fielding AK, Foà R, Gökbuget N, Goldstone AH, Goulden N, Henze G, Hoelzer D, Janka-Schaub GE, Macintyre EA,
Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJ.
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment
in Kiel, Germany, 18-20 September 2008.
LEUKEMIA 2009; doi:10.1038/leu.2009.268.
IF: 8,296
D Gallardo, R Cámara, JB Nieto, I Espigado, A Iriondo, A Jiménez-Velasco, C Vallejo, C Martin, D Caballero, S Brunet, D Serrano, C
Solano, JM Ribera, J de la Rubia, E Carreras.
Is mobilized peripheral blood stem cells comparable with bone marrow as a source of hematopoietic cells for allogeneic
transplantation from HLA-identical sibling donors. A case – control study.
HAEMATOL-HEMATOL J 2009; 94:1282-8
IF: 6,416
Danesi, R; Altavilla, G; Giovannetti, E; Rosell, R
Pharmacogenomics of gemcitabine in non-small-cell lung cancer and other solid tumors
PHARMACOGENOMICS 2009-JAN; 10 (1): 69-80
IF: 3,991
Danesi, R; Pasqualetti, G; Giovannetti, E; Crea, F; Altavilla, G; Del Tacca, M; Rosell, R
Pharmacogenomics in non-small-cell lung cancer chemotherapy
ADV DRUG DELIVER REV 2009-MAY 20; 61 (5): 408-417
IF: 11,957
Giros A, Grzybowski M, Sohn VR, Pons E, Fernandez-Morales J, Xicola RM, Sethi P, Grzybowski J, Goel A, Boland CR, Gassull MA,
Llor X.
Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids Docosahexaenoic and Eicosapentaenoic.
CANCER PREV RES 2009 Aug;2(8):732-42. Epub 2009 Jul 28.
IF: 4,678
Hilari JM, Mangas C, Xi L, Paradelo C, Ferrándiz C, Hughes SJ, Yueh C, Altomare I, Gooding WE, Godfrey TE.
Molecular Staging of Pathologically Negative Sentinel Lymph Nodes from Melanoma Patients Using Multimarker, Quantitative
Real-Time RT-PCR.
ANN SURG ONCOL 2009 Jan;16(1):177-85. Epub 2008 Nov 4
IF: 4,130
Isla, D; Cobo, M; Ramirez, JL; Sanchez-Ronco, M; de Aguirre, I; Provencio, M; Lopez-Vivanco, G; Camps, C; Domine, M; Alberola, V;
Taron, M; Rosell, R
Blood-based CHRNA3 single nucleotide polymorphisms (SNPs) and outcome in advanced non-small-cell lung cancer (NSCLC)
patients
J THORAC ONCOL 2009-SEP; 4 (9): S536-S537
IF: 4,547
Pàgina 39 de 67